Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Participants

NCT02065700 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

739

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Filgotinib

Sponsor

Lakefront Biotherapeutics NV

Collaborators

[object Object]